Viking Therapeutics, Inc.
2019 Q4 - 2025 Q4 (20 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 854 | 0.0% | 24,272 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 572 | 0.0% | 21,590 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 579 | 0.0% | 23,981 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 993 | 0.0% | 24,676 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,559 | 0.0% | 24,630 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 1,085 | 0.0% | 20,474 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 4,482 | 0.0% | 54,654 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 876 | 0.0% | 47,073 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 532 | 0.0% | 48,045 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 600 | 0.0% | 36,996 | 6/30/2023 |
| 2022 Q1 | 8/11/2023 | 95 | 0.0% | 31,790 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 184 | 0.0% | 39,969 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 247 | 0.0% | 39,333 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 252 | 0.0% | 42,065 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 253 | 0.0% | 40,019 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 235 | 0.0% | 41,757 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 232 | 0.0% | 39,902 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 290 | 0.0% | 39,902 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 198 | 0.0% | 42,248 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 319 | 0.0% | 39,790 | 12/31/2019 |